BMC Systems Biology
暂无分享,去创建一个
Joel H. Saltz | Huaxia Qin | Michael W. Y. Chan | Sandya Liyanarachchi | Curtis Balch | Dustin P. Potter | Irene J. Souriraj | Alfred S. L. Cheng | Francisco J. Agosto-Perez | Elena Nikonova | Pearlly Yan | Huey-Jen Lin | Kenneth P. Nephew | Louise C. Showe | Tim Hui-Ming Huang | Ramana V. Davuluri | S. Liyanarachchi | K. Nephew | J. Saltz | R. Davuluri | J. Saltz | T. Huang | L. Showe | C. Balch | P. Yan | Elena Nikonova | D. Potter | A. S. Cheng | Francisco J. Agosto-Perez | E. Nikonova | Huey-Jen Lin | M. Chan | Huaxia Qin | A. S. Cheng | T. Huang | Michael WY Chan | I. J. Souriraj | Huey-Jen Lin
[1] H. Parviainen,et al. GATA-4 is a granulosa cell factor employed in inhibin-alpha activation by the TGF-beta pathway. , 2006, Journal of molecular endocrinology.
[2] P. Mellon,et al. Activin regulation of the follicle-stimulating hormone beta-subunit gene involves Smads and the TALE homeodomain proteins Pbx1 and Prep1. , 2004, Molecular endocrinology.
[3] J. Massagué,et al. Transcriptional control by the TGF‐β/Smad signaling system , 2000 .
[4] Dongsun Cao,et al. Bone Morphogenetic Protein Signaling Modulates Myocardin Transactivation of Cardiac Genes , 2005, Circulation research.
[5] Roger R. Gomis,et al. C/EBPβ at the core of the TGFβ cytostatic response and its evasion in metastatic breast cancer cells , 2006 .
[6] John J. Wyrick,et al. Genome-wide location and function of DNA binding proteins. , 2000, Science.
[7] Huaxia Qin,et al. Aberrant transforming growth factor beta1 signaling and SMAD4 nuclear translocation confer epigenetic repression of ADAM19 in ovarian cancer. , 2008, Neoplasia.
[8] R. Derynck,et al. TGF-β signaling in cancer – a double-edged sword , 2001 .
[9] Curt Balch,et al. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. , 2008, Cancer research.
[10] J. Massagué,et al. C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells. , 2006, Cancer cell.
[11] Andrew Leask,et al. The induction of CCN2 by TGFβ1 involves Ets-1 , 2006, Arthritis research & therapy.
[12] Michael S. German,et al. Paired-Homeodomain Transcription Factor PAX4 Acts as a Transcriptional Repressor in Early Pancreatic Development , 1999, Molecular and Cellular Biology.
[13] Megan F. Cole,et al. Control of Developmental Regulators by Polycomb in Human Embryonic Stem Cells , 2006, Cell.
[14] P. Santisteban,et al. The Functional Interaction between the Paired Domain Transcription Factor Pax8 and Smad3 Is Involved in Transforming Growth Factor-β Repression of the Sodium/Iodide Symporter Gene* , 2004, Journal of Biological Chemistry.
[15] J. Massagué,et al. Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.
[16] Tim Hui-Ming Huang,et al. MPromDb: an integrated resource for annotation and visualization of mammalian gene promoters and ChIP-chip experimental data , 2005, Nucleic Acids Res..
[17] Santiago Lamas,et al. Functional Cooperation Between Smad Proteins and Activator Protein-1 Regulates Transforming Growth Factor-&bgr;–Mediated Induction of Endothelin-1 Expression , 2003, Circulation research.
[18] Terje Johansen,et al. The MH1 domain of Smad3 interacts with Pax6 and represses autoregulation of the Pax6 P1 promoter , 2007, Nucleic acids research.
[19] K. Lunetta,et al. Identifying SNPs predictive of phenotype using random forests , 2005, Genetic epidemiology.
[20] Todd Evans,et al. An Oct-1 binding site mediates activation of the gata2 promoter by BMP signaling , 2005, Nucleic acids research.
[21] L. Attisano,et al. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[22] Christian Sirard,et al. Smad4 and β-Catenin Co-activators Functionally Interact with Lymphoid-enhancing Factor to Regulate Graded Expression of Msx2* , 2003, Journal of Biological Chemistry.
[23] Wei He,et al. A FoxO–Smad synexpression group in human keratinocytes , 2006, Proceedings of the National Academy of Sciences.
[24] S. Dudoit,et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. , 2002, Nucleic acids research.
[25] Megan F. Cole,et al. Core Transcriptional Regulatory Circuitry in Human Embryonic Stem Cells , 2005, Cell.
[26] Kyucheol Cho,et al. Transforming growth factor-β1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-κB, JNK, and Ras signaling pathways , 2003, Oncogene.
[27] Ken Yagi,et al. c-myc Is a Downstream Target of the Smad Pathway* 210 , 2002, The Journal of Biological Chemistry.
[28] Mark Hurle,et al. Revealing transforming growth factor-beta signaling transduction in human kidney by gene expression data mining. , 2005, Omics : a journal of integrative biology.
[29] E. Wingender,et al. MATCH: A tool for searching transcription factor binding sites in DNA sequences. , 2003, Nucleic acids research.
[30] J. Massagué,et al. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. , 2003, Cell.
[31] Denis Vivien,et al. Direct binding of Smad3 and Smad4 to critical TGFβ‐inducible elements in the promoter of human plasminogen activator inhibitor‐type 1 gene , 1998, The EMBO journal.
[32] Shi Lei,et al. Synergistic activation of the murine gastrin promoter by oncogenic Ras and beta-catenin involves SMAD recruitment. , 2005, Biochemical and biophysical research communications.
[33] Michael Q. Zhang,et al. Mining ChIP-chip data for transcription factor and cofactor binding sites , 2005, ISMB.
[34] Robert Walgate,et al. Proliferation , 1985, Nature.
[35] Alexander E. Kel,et al. MATCHTM: a tool for searching transcription factor binding sites in DNA sequences , 2003, Nucleic Acids Res..
[36] J. Massagué,et al. Smad transcription factors. , 2005, Genes & development.
[37] A. Moustakas,et al. Mechanism of a transcriptional cross talk between transforming growth factor-beta-regulated Smad3 and Smad4 proteins and orphan nuclear receptor hepatocyte nuclear factor-4. , 2003, Molecular biology of the cell.
[38] D. Berger,et al. Cooperation between GATA4 and TGF-beta signaling regulates intestinal epithelial gene expression. , 2007, American journal of physiology. Gastrointestinal and liver physiology.
[39] T. Shioda,et al. The Smad4 Activation Domain (SAD) Is a Proline-rich, p300-dependent Transcriptional Activation Domain* , 2000, The Journal of Biological Chemistry.
[40] Sandya Liyanarachchi,et al. Combinatorial analysis of transcription factor partners reveals recruitment of c-MYC to estrogen receptor-alpha responsive promoters. , 2006, Molecular cell.
[41] Fang Liu,et al. Activation of Smad transcriptional activity by protein inhibitor of activated STAT3 (PIAS3) , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[42] S. Anderson,et al. Integration of Smad and Forkhead Pathways in the Control of Neuroepithelial and Glioblastoma Cell Proliferation , 2004, Cell.
[43] Jian Wang,et al. Dickkopf-1, an inhibitor of the Wnt signaling pathway, is induced by p53 , 2000, Oncogene.
[44] Kunihiro Tsuchida,et al. Transcriptional Activation of Mouse Mast Cell Protease-7 by Activin and Transforming Growth Factor-β Is Inhibited by Microphthalmia-associated Transcription Factor* , 2003, Journal of Biological Chemistry.
[45] Neil D. Lawrence,et al. A Comparison of State-of-the-Art Classification Techniques with Application to Cytogenetics , 2001, Neural Computing & Applications.
[46] R. Derynck,et al. TGF-beta signaling in cancer--a double-edged sword. , 2001, Trends in cell biology.
[47] R. Tjian,et al. Diversified transcription initiation complexes expand promoter selectivity and tissue-specific gene expression. , 2003, Genes & development.
[48] J. Massagué,et al. Opposite Smad and Chicken Ovalbumin Upstream Promoter Transcription Factor Inputs in the Regulation of the Collagen VII Gene Promoter by Transforming Growth Factor-β* , 2004, Journal of Biological Chemistry.
[49] Steven Gallinger,et al. Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis. , 2007, Cancer research.
[50] Ying Cao,et al. The POU Factor Oct-25 Regulates the Xvent-2B Gene and Counteracts Terminal Differentiation in Xenopus Embryos* , 2004, Journal of Biological Chemistry.
[51] Jouni Uitto,et al. Transcriptional control of the mouse Col7a1 gene in keratinocytes: basal and transforming growth factor-beta regulated expression. , 2003, The Journal of investigative dermatology.
[52] Hiroshi Furukawa,et al. PAX4 has the potential to function as a tumor suppressor in human melanoma. , 2008, International journal of oncology.
[53] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[54] Clifford A. Meyer,et al. Genome-wide analysis of estrogen receptor binding sites , 2006, Nature Genetics.
[55] M. L. Howard,et al. cis-Regulatory control circuits in development. , 2004, Developmental biology.
[56] Marc S. Halfon,et al. Prediction of similarly acting cis-regulatory modules by subsequence profiling and comparative genomics in Drosophila melanogaster and D.pseudoobscura , 2004, Bioinform..
[57] Stefano Piccolo,et al. Integration of TGF-ß and Ras/MAPK Signaling Through p53 Phosphorylation , 2007, Science.
[58] Leo Breiman,et al. Classification and Regression Trees , 1984 .
[59] Marc Tessier-Lavigne,et al. The Hedgehog, TGF-beta/BMP and Wnt families of morphogens in axon guidance. , 2007, Advances in experimental medicine and biology.
[60] J. Williams,et al. STAT signalling in cell proliferation and in development. , 2000, Current opinion in genetics & development.
[61] N. Wake,et al. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer. , 2000, Cancer research.
[62] T. Gelehrter,et al. Smad4/DPC4 and Smad3 Mediate Transforming Growth Factor-β (TGF-β) Signaling through Direct Binding to a Novel TGF-β-responsive Element in the Human Plasminogen Activator Inhibitor-1 Promoter* , 1998, The Journal of Biological Chemistry.
[63] David S Alberts,et al. Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers. , 2005, Human pathology.
[64] Murray Korc,et al. Smad7 Abrogates Transforming Growth Factor-β1-mediated Growth Inhibition in COLO-357 Cells through Functional Inactivation of the Retinoblastoma Protein* , 2005, Journal of Biological Chemistry.
[65] Stephen B. Howell,et al. Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers. , 2005, Human pathology.
[66] J. Winderickx,et al. Inferring transcriptional modules from ChIP-chip, motif and microarray data , 2006, Genome Biology.
[67] A. Okamoto,et al. Allelic imbalance in chromosome band 18q21 and SMAD4 mutations in ovarian cancers , 1999, Genes, chromosomes & cancer.
[68] M. Barton,et al. A Direct Intersection between p53 and Transforming Growth Factor β Pathways Targets Chromatin Modification and Transcription Repression of the α-Fetoprotein Gene , 2005, Molecular and Cellular Biology.
[69] Takayuki Furumatsu,et al. Smad3 Induces Chondrogenesis through the Activation of SOX9 via CREB-binding Protein/p300 Recruitment*[boxs] , 2005, Journal of Biological Chemistry.
[70] Mikko Anttonen,et al. GATA-4 is a granulosa cell factor employed in inhibin-α activation by the TGF-β pathway , 2006 .
[71] Yudong D. He,et al. Functional Discovery via a Compendium of Expression Profiles , 2000, Cell.
[72] J. Massagué,et al. E2F4/5 and p107 as Smad Cofactors Linking the TGFβ Receptor to c-myc Repression , 2002, Cell.
[73] R. W. Padgett,et al. Genome-wide microarray analysis of TGFβ signaling in the Drosophila brain , 2004, BMC Developmental Biology.
[74] Beth Y Karlan,et al. Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling. , 2003, Cancer research.
[75] M. Skinner,et al. Autocrine interactions of keratinocyte growth factor, hepatocyte growth factor, and kit-ligand in the regulation of normal ovarian surface epithelial cells. , 2000, Endocrinology.
[76] A. Grinberg,et al. Both Max and TFE3 Cooperate with Smad Proteins to Bind the Plasminogen Activator Inhibitor-1 Promoter, but They Have Opposite Effects on Transcriptional Activity* 210 , 2003, The Journal of Biological Chemistry.
[77] Anping Chen,et al. Disruption of transforming growth factor-beta signaling by curcumin induces gene expression of peroxisome proliferator-activated receptor-gamma in rat hepatic stellate cells. , 2007, American journal of physiology. Gastrointestinal and liver physiology.
[78] Liliana Attisano,et al. Synergistic Cooperation between Hypoxia and Transforming Growth Factor-β Pathways on Human Vascular Endothelial Growth Factor Gene Expression* , 2001, The Journal of Biological Chemistry.
[79] Robert Gentleman,et al. R Programming for Bioinformatics , 2008 .
[80] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[81] M. Barton,et al. A direct intersection between p53 and transforming growth factor beta pathways targets chromatin modification and transcription repression of the alpha-fetoprotein gene. , 2005, Molecular and cellular biology.
[82] F. Hoffmann,et al. Smad4 cooperates with lymphoid enhancer-binding factor 1/T cell-specific factor to increase c-myc expression in the absence of TGF-β signaling , 2006, Proceedings of the National Academy of Sciences.
[83] Peter Scheurich,et al. p53 upregulates cFLIP, inhibits transcription of NF-κB-regulated genes and induces caspase-8-independent cell death in DLD-1 cells , 2001, Oncogene.
[84] Anping Chen,et al. Disruption of transforming growth factor-β signaling by curcumin induces gene expression of peroxisome proliferator-activated receptor-γ in rat hepatic stellate cells , 2007 .
[85] Stefano Piccolo,et al. Integration of TGF-beta and Ras/MAPK signaling through p53 phosphorylation. , 2007, Science.
[86] A. Balmain,et al. TGF-beta signaling in tumor suppression and cancer progression. , 2001, Nature genetics.
[87] Adele Cutler,et al. Random forests for microarrays. , 2006, Methods in enzymology.
[88] Malte Buchholz,et al. Sp1 is required for transforming growth factor-beta-induced mesenchymal transition and migration in pancreatic cancer cells. , 2007, Cancer research.
[89] F. Verrecchia,et al. Retinoic acid receptors interfere with the TGF-β/Smad signaling pathway in a ligand-specific manner , 2003, Oncogene.
[90] Barbara C Vanderhyden,et al. Transforming growth factor-β regulates Kit ligand expression in rat ovarian surface epithelial cells , 1999, Oncogene.
[91] J. Foley,et al. Parathyroid hormone-related protein gene expression in human squamous carcinoma cells is repressed by mutant isoforms of p53. , 1996, Cancer research.
[92] R. Bast,et al. Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-beta. , 1992, American journal of obstetrics and gynecology.
[93] R. L. Baldwin,et al. Ovarian carcinoma cell cultures are resistant to TGF-beta1-mediated growth inhibition despite expression of functional receptors. , 1999, Gynecologic oncology.
[94] K. Miyazono,et al. Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300. , 1999, Science.
[95] Hongyu Zhao,et al. Pathway analysis using random forests classification and regression , 2006, Bioinform..
[96] R S Ismail,et al. Transforming growth factor-beta regulates Kit ligand expression in rat ovarian surface epithelial cells. , 1999, Oncogene.
[97] R. Derynck,et al. SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS , 2005 .
[98] F. Robert,et al. Genome-wide computational prediction of transcriptional regulatory modules reveals new insights into human gene expression , 2006 .
[99] S. Mok,et al. Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta signaling in ovarian cancer. , 2006, Cancer research.
[100] K. Lunetta,et al. Screening large-scale association study data: exploiting interactions using random forests , 2004, BMC Genetics.
[101] R. Derynck,et al. Specificity and versatility in tgf-beta signaling through Smads. , 2005, Annual review of cell and developmental biology.
[102] Anthony A. Philippakis,et al. Expression-Guided In Silico Evaluation of Candidate Cis Regulatory Codes for Drosophila Muscle Founder Cells , 2006, PLoS Comput. Biol..
[103] T. Speed,et al. Summaries of Affymetrix GeneChip probe level data. , 2003, Nucleic acids research.
[104] Chris Sander,et al. Signal Processing in the TGF-β Superfamily Ligand-Receptor Network , 2005, PLoS Comput. Biol..
[105] S. Yamashita,et al. Dexamethasone inhibition of TGF beta-induced cell growth and type II collagen mRNA expression through ERK-integrated AP-1 activity in cultured rat articular chondrocytes. , 2000, Osteoarthritis and cartilage.
[106] Xiao-Fan Wang,et al. Functional Analysis of the Transforming Growth Factor βResponsive Elements in the WAF1/Cip1/p21 Promoter (*) , 1995, The Journal of Biological Chemistry.
[107] Dipak P. Ramji,et al. A critical role for the Sp1-binding sites in the transforming growth factor-β-mediated inhibition of lipoprotein lipase gene expression in macrophages , 2005, Nucleic acids research.